Department of Otolaryngology, West China Hospital, Sichuan University, Chengdu, China; Department of Allergy, Royal National Throat Nose Ear Hospital, University College London, London, United Kingdom.
Department of Allergy, Royal National Throat Nose Ear Hospital, University College London, London, United Kingdom.
Ann Allergy Asthma Immunol. 2016 Sep;117(3):273-9. doi: 10.1016/j.anai.2016.07.009.
Penicillin allergy is associated with increased antibiotic resistance and health care costs. However, most patients with self-reported penicillin allergy are not truly allergic.
To summarize our experience with allergy tests in patients with a history of penicillin allergy and to compare them with the results of other groups.
We retrospectively reviewed all patients with a suspected clinical history of penicillin allergy referred to the Drug Allergy Unit at University College London Hospital between March 2013 and June 2015.
In total, 84 patients were reviewed. The index drugs included: unidentified penicillin (n = 44), amoxicillin (n = 17), amoxicillin-clavulanic acid (n = 13), flucloxacillin (n = 4), and other penicillins (ampicillin, benzylpenicillin, piperacillin-tazobactam; n = 7). Allergy diagnoses were confirmed in 24 patients (28.6%) (16 to penicillin, 3 to flucloxacillin, 5 to clavulanic acid). Twenty-two patients (91.7%) had allergy diagnosed by positive skin test results. Two patients (8.3%) developed IgE-mediated allergic symptoms during oral challenge (although the skin test results were negative). In vitro specific IgE test results for penicilloyl V, penicilloyl G, and amoxicilloyl were positive in 3 of 16 patients (18.8%). Moreover, reactions to cefuroxime were observed in 3 of 15 patients with penicillin allergy (20%). Selective clavulanic acid and flucloxacillin responders tolerated amoxicillin challenge. The interval between the index reaction and evaluation was shorter (P < .001), and the proportion of patients who could recall the name of the culprit drug was higher (P = .009) in the allergic group. Furthermore, histories of anaphylaxis (33.3%), urticaria, and/or angioedema (58.3%) were more common in the allergic group. Unspecified rashes (35.0%) and nonspecific symptoms (28.3%) predominated in the nonallergic group.
Only 28.6% of patients with self-reported penicillin allergy were confirmed to be allergic. Importantly, when the index drug is amoxicillin-clavulanic acid or flucloxacillin, the patients may tolerate amoxicillin.
青霉素过敏与抗生素耐药性和医疗保健费用增加有关。然而,大多数自我报告有青霉素过敏史的患者并非真正过敏。
总结我们在有青霉素过敏史的患者中进行过敏测试的经验,并将其结果与其他组进行比较。
我们回顾性分析了 2013 年 3 月至 2015 年 6 月期间在伦敦大学学院医院药物过敏科就诊的疑似有青霉素过敏史的所有患者。
共回顾了 84 例患者。索引药物包括:未识别的青霉素(n=44)、阿莫西林(n=17)、阿莫西林-克拉维酸(n=13)、氟氯西林(n=4)和其他青霉素(氨苄西林、青霉素 G、哌拉西林-他唑巴坦;n=7)。24 例患者(28.6%)被确诊为过敏(16 例对青霉素过敏,3 例对氟氯西林过敏,5 例对克拉维酸过敏)。22 例患者(91.7%)通过皮试阳性结果确诊过敏。2 例患者(8.3%)在口服激发试验中出现 IgE 介导的过敏症状(尽管皮试结果为阴性)。16 例患者中有 3 例(18.8%)青霉素酰基 V、青霉素酰基 G 和阿莫西林酰基的体外特异性 IgE 检测结果为阳性。此外,15 例青霉素过敏患者中有 3 例(20%)出现头孢呋辛反应。选择性克拉维酸和氟氯西林反应者可耐受阿莫西林激发试验。过敏组的索引反应与评估之间的间隔更短(P<0.001),能回忆起致敏药物名称的患者比例更高(P=0.009)。此外,过敏组更常见过敏反应(33.3%)、荨麻疹和/或血管性水肿(58.3%)。非过敏组以未明确的皮疹(35.0%)和非特异性症状(28.3%)为主。
只有 28.6%的自我报告有青霉素过敏史的患者被确认为过敏。重要的是,当索引药物为阿莫西林-克拉维酸或氟氯西林时,患者可能耐受阿莫西林。